The 10 autosomal recessive limb-girdle muscular dystrophies

Neuromuscular Disorders

Volumn 13, Issue 7-8, 2003, Pages 532-544

  Zatz, Mayana ^a   De Paula, Flavia ^a   Starling, Alessandra ^a   Vainzof, Mariz ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Genotype phenotype correlation; Inter and intrafamilial variability; Limb girdle muscular dystrophy

Indexed keywords

CALPAIN 3; DYSFERLIN; DYSTROPHIN; PROTEIN; SARCOGLYCAN; TELETHONIN; UNCLASSIFIED DRUG;

AUTOSOMAL RECESSIVE INHERITANCE; CALPAINOPATHY; CLINICAL FEATURE; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE COURSE; DNA DETERMINATION; DYSFERLINOPATHY; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC LINKAGE; GENOTYPE; HETEROZYGOTE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MIYOSHI MYOPATHY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; REVIEW; SARCOGLYCANOPATHY; SEX DIFFERENCE; TELETHONINOPATHY;

EID: 0042071489     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(03)00100-7     Document Type: Review

References (109)

1. Bushby K.M.D. The limb-girdle muscular dystrophies: multiple genes, multiple mechanisms. Hum Mol Genet. 8:1999;1875-1882.
2. Zatz M., Vainzof M., Passos-Bueno M.R., et al. Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes. Curr Opin Neurol. 13:(5):2000;511-517. [Review].
3. Starling A.L., Vainzof M., Pavanello R., et al. Evidence of further genetic heterogeneity for both autosomal dominant and autosomal recessive limb-girdle muscular dystrophy. Am J Hum Genet. 69:(4):2001;1942. [Suppl 1].
4. Beckmann J.S., Richard I., Hillarie D., et al. A gene for limb girdle muscular dystrophy maps to chromosome 15 by linkage. C R Acad Sci Paris. 132:1991;141-148.
5. Passos-Bueno M.R., Richard I., Vainzof M., et al. Evidence of genetic heterogeneity for the autosomal recessive adult forms of limb-girdle muscular dystrophy following linkage analysis with 15q probes in Brazilian families. J Med Genet. 30:(5):1993;385-387.
6. Richard I., Broux O., Allamand V., et al. A novel mechanism leading to muscular dystrophy: mutations in calpain 3 cause limb girdle muscular dystrophy type 2A. Cell. 81:1995;27-40.
7. Bashir R., Britton S., Stratchan T., et al. A novel mammalian gene related to the C. elegans spermatogenesis factor fer-1 is mutated in patients with limb-girdle muscular dystrophy type 2B (LGMD2B). Nat Genet. 20:1988;37-42.
8. Liu J., Aoki M., Illa I., et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet. 20:1998;31-36.
9. Roberds S.L., Leturcq F., Allamand V., et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell. 78:1994;625-633.
10. McNally E.M., Yoshida M., Mizuno Y., Ozawa E., Kunkel L.M. Human adhalin is alternatively spliced and the gene is located on chromosome 17q21. Proc Natl Acad Sci. 91:1994;9690-9694.
11. Lim L.E., Duclos F., Allamand V., et al. β-Sarcoglycan (43 DAG): characterization and involvement in a recessive form of limb-girdle muscular dystrophy linked to chromosome 4q12. Nat Genet. 11:1995;257-265.
12. Bönnemann C.G., Modi R., Noguchi S., et al. Mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet. 11:1995;266-273.
13. Noguchi S., McNally E.M., Ben Othmane K., et al. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science. 270:1995;819-822.
14. McNally E., Passos-Bueno M.R., Bonnemann C., et al. Mild and severe muscular dystrophy caused by a single γ-sarcoglycan mutation. Am J Hum Genet. 59:1996;1040-1047.
15. Passos-Bueno M.R., Moreira E.S., Vainzof M., Marie S.K., Zatz M. Linkage analysis in autosomal recessive limb-girdle muscular dystrophy (AR-LGMD) maps a sixth form to 5q33-34 (LGMD2F) and indicates that there is at least one more subtype of AR LGMD. Hum Mol Genet. 5:1996;815-820.
16. Nigro V., Moreira E.S., Piluso G., et al. The 5q autosomal recessive limb-girdle muscular dystrophy (LGMD2F) is caused by a mutation in the δ-sarcoglycan gene. Nat Genet. 14:1996;195-196.
17. Nigro V., Piluso G., Belsito A., et al. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein. Hum Mol Genet. 5:1996;1179-1186.
18. Moreira E.S., Vainzof M., Marie S.K., Sertié A.L., Zatz M., Passos-Bueno M.R. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet. 61:1997;151-159.
19. Moreira E.S., Wiltshire T.J., Faulkner G., et al. Limb-girdle muscular dystrophy type 2G (LGMD 2G) is caused by mutations in the gene encoding the sarcomeric protein Telethonin. Nat Genet. 24:2000;163-166.
20. Frosk P., Weiler T., Nylen E., et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet. 70:(3):2002;663-672.
21. Brockington M., Yuva Y., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet. 10:(25):2001;2851-2859.
22. Bushby K.M.D., Beckmann J.S. The 105th ENMC sponsored workshop: pathogenesis in the non-sarcoglycan limb-girdle muscular dystrophies, Naarden, April 12-14, 2002. Neuromuscul Disord. 13:2003;80-90.
23. Richard I., Roudaut C., Saenz A., et al. Calpainopathy: a survey of mutations and polymorphisms. Am J Hum Genet. 64:1999;1524-1540.
24. Pollitt C., Anderson L.V., Pogue R., Davison K., Pyle A., Bushby K.M. The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach. Neuromuscul Disord. 11:(3):2001;287-296.
25. Paula F., Vainzof M., Passos-Bueno M.R., et al. Clinical variability in calpainopathy: what makes the difference? Eur J Hum Genet. 10:(12):2002;825-832.
26. Fanin M., Pegoraro E., Matsuda-Asada C., Brown R.H., Angelini C. Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy. Neurology. 1:2001;660-665.
27. Chae J., Minami N., Jin Y., et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord. 11:(6-7):2001;547-555.
28. Urtasun M., Saenz A., Roudaut C., et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country Spain). Brain. 121:(Pt 9):1998;1735-1747.
29. Fardeau M., Eymard B., Mignard C., Tome F.M., Richard I., Beckmann J.S. Chromosome 15-linked limb-girdle muscular dystrophy: clinical phenotypes in Reunion Island and French metropolitan communities. Neuromuscul Disord. 6:(6):1996;447-453.
30. Anderson L.V., Davison K., Moss J.A., et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol. 153:(4):1998;1169-1179.
31. Sorimachi H., Beckmann J.S. Defects of non-lysosomal proteolysis: calpain3 deficiency. Karpati G. Structural and molecular basis of skeletal muscle diseases. 2002;148-153 ISN Neuropath Press, Basel.
32. Vainzof M., Anderson L.V.B., Moreira E.S., et al. Characterization of the primary defect in LGMD2A and analysis of its secondary effect in other LGMDs. Neurology. 54:2000;A436.
33. Vainzof M., Moreira E.S., Passos-Bueno M.R., et al. The effect of telethonin deficiency in LGMD-2G and its expression in other forms of muscular dystrophies and congenital myopathies. BBA - Gene Basis Dis. 1588:(1):2002;33-40.
34. Anderson L.V., Harrison R.M., Pogue R., et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord. 10:2000;553-559.
35. Vainzof M., Pavanello R.C.M., Anderson L.V.B., Moreira E.S., Passos-Bueno M.R., Zatz M. Dysferlin analysis in autosomal recessive limb-girdle muscular dystrophies (AR-LGMD). J Mol Neurosci. 17:2001;71-80.
36. Haravuori H., Vihola A., Straub V., et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology. 56:(7):2001;869-877.
37. Garvey S.M., Rajan C., Lerner A.P., Frankel W.N., Cox G.A. The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. Genomics. 79:(2):2002;146-149.
38. Hackman P., Richard I., Vihola A., et al. Tibial muscular dystrophy (TMD), 2q31 linked myopathy: sequencing and functional studies of the titin (TTN) gene. J Neurol Sci. 199:(Suppl 1):2002;S35.
39. Carafoli E., Molinari M. Calpain: a protease in search of a function? Biochem Biophys Res Commun. 247:(2):1998;193-203. [Review].
40. Ono Y., Sorimachi H., Suzuki K. Structure and physiology of calpain, an enigmatic protease. Biochem Biophys Res Commun. 245:(2):1998;289-294.
41. Suzuki K., Sorimachi H. A novel aspect of calpain activation. FEBS Lett. 433:1998;1-4. [Review].
42. Beckmann J.S., Fardeau M. Limb-girdle muscular dystrophies. Emery A.E.H. Neuromuscular disorders: clinical and molecular genetics. 1998;123-156 Wiley & Sons Ltd, Chichester.
43. Baghdiguian S., Martin M., Richard I., et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med. 5:(5):1999;503-511.
44. Passos-Bueno M.R., Vainzof M., Moreira E.S., Zatz M. The seven autosomal recessive limb-girdle muscular dystrophy (LGMD): from LGMD2A to LGMD2G. Am J Med Genet. 82:1999;392-398.
45. Matsuda C., Aoki M., Hayashi Y., Arahata K., Brown R.H. Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy. Neurology. 53:1999;1119-1122.
46. Illa I., Serrrano-Munuera C., Gallardo E., et al. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol. 49:2001;130-134.
47. Illarioshkin S.N., Ivanova-Smolenskaya I.A., Greenberg C.R., et al. Identical dysferlin mutation in limb girdle muscular dystrophy type 2B and dystal myopathy. Neurology. 55:2000;1931-1933.
48. Anderson L.V., Davison K., Moss J.A., et al. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet. 8:1999;855-861.
49. Ho M., Gallardo E., McKenna-Yasek D., De Luna N., Illa I., Brown R.H. Jr. A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy. Ann Neurol. 51:(1):2002;129-133.
50. Piccolo F., Moore S.A., Ford G.C., Campbell K.P. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies. Ann Neurol. 48:(6):2000;902-912.
51. Matsuda C., Hayashi Y.K., Ogawa M., et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet. 10:(17):2001;1761-1766.
52. Davis D.B., Delmonte A.J., Ly C.T., McNally E.M. Myoferlin, a candidate gene and potential modified of muscular dystrophy. Hum Mol Genet. 9:2000;217-226.
53. Paula F., Vainzof M., Moreira E.S., et al. Novel dysferlin mutations in Brazilian LGMD2B patients. Am J Hum Genet. 69:(4):2001;639. [Suppl 1].
54. McNally E.M., Ly C.T., Rosenmmann H., et al. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet. 91:2000;305-312.
55. Weiler T., Bashir R., Anderson L.V., et al. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet. 8:(5):1999;871-877.
56. Bittner R.E., Anderson L.V., Burkhardt E., et al. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet. 23:(2):1999;141-142.
57. Fanin M., Duggan D.J., Mostacciuolo M.L., et al. Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J Med Genet. 34:1997;973-977.
58. Vainzof M., Passos-Bueno M.R., Pavanello R.C., Marie S.K., Oliveira A.S., Zatz M. Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population. J Neurol Sci. 164:1999;44-49.
59. Bushby K.M. Making sense of the limb-girdle muscular dystrophies. Brain. 122:1999;1403-1420.
60. Duggan D.J., Gorospe J.R., Fanin M., Hoffman E.P., Angelini C. Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med. 336:1997;618-624.
61. Duclos F., Broux O., Bourg N., et al. Beta-sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate. Neuromuscul Disord. 8:1998;30-38.
62. Passos-Bueno M.R., Moreira E.S., Marie S.K., et al. Main clinical features for the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families. J Med Genet. 33:1996;97-102.
63. Yoshida M., Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem. 108:1990;748-752.
64. Ervasti J.M., Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell. 66:1991;1121-1131.
65. Ozawa E., Noguchi S., Mizuno Y., Hagiwara Y., Yoshida M. From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve. 21:1998;421-438.
66. Rando T.A. The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve. 24:2001;1575-1594.
67. Crosbie R.H., Lebakken C.S., Holt K.H., et al. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol. 145:1999;153-165.
68. Ettinger A.J., Feng G., Sanes J.R. Epsilon-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem. 272:1997;32534-32538.
69. McNally E.M., Ly C.T., Kunkel L.M. Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett. 422:1998;27-32.
70. Straub V., Ettinger A.J., Durbeej M., et al. Epsilon-sarcoglycan replaces alpha-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex. J Biol Chem. 274:1999;27989-27996.
71. Zimprich A., Grabowski M., Asmus F., et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet. 29:2001;66-69.
72. Muller B., Hedrich K., Kock N., et al. Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet. 71:(6):2002;1303-1311.
73. Angelini C., Fanin M., Freda M.P., Duggan D.J., Siciliano G., Hoffman E.P. The clinical spectrum of sarcoglycanopathies. Neurology. 52:1999;176-179.
74. Duggan D.J., Manchester D., Stears K.P., Mathews D.J., Kart C., Hoffman E.P. Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Neurogenetics. 1:1997;49-58.
75. Othmane K.B., Speer M., Stauffer J., et al. Evidence for linkage disequilibrium in chromosome 13-linked Duchenne-like muscular dystrophy (LGMD2C). Am J Hum Genet. 57:1995;732-734.
76. Moreira E.S., Vainzof M., Suzuki O.T., Pavanello R.C.M., Zatz M., Passos-Bueno M.R. Genotype/phenotype correlations on 35 Brazilian families with sarcoglycanopathies, including the description of three novel mutations. J Med Genet. 40:(2):2003;E12.
77. Moreira E.S., Vainzof M., Marie S.K., Nigro V., Zatz M., Passos-Bueno M.R. A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies. J Med Genet. 35:1998;951-953.
78. Passos-Bueno M.R., Moreira E.S., Vainzof M., et al. A common missense mutation in the adhalin gene in three unrelated Brazilian families with a relatively mild form of autosomal recessive limb-girdle muscular dystrophy. Hum Mol Genet. 4:1995;163-167.
79. Piccolo F., Roberds S.L., Jeanpierre M., et al. Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet. 10:1995;243-245.
80. Carrié A., Piccolo F., Leturcq F., et al. Mutational diversity and hotspots in the α-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J Med Genet. 34:1997;470-475.
81. Eymard B., Romero N.B., Leturcq F., et al. Primary adhalinopathy (α-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology. 48:1997;1227-1234.
82. Campbell K.P., Kahl S.D. Association of dystrophin and an integral membrane glycoprotein. Nature. 338:1989;259-262.
83. Cohn R.D., Campbell K.P. Molecular basis of muscular dystrophies. Muscle Nerve. 23:2000;1456-1471.
84. Hack A.A., Groh M.E., McNally E.M. Sarcoglycans in muscular dystrophy. Microsc Res Tech. 48:2000;167-180.
85. Bönnemann C.G. Limb-girdle muscular dystrophies: an overview. J Child Neurol. 14:1999;31-33.
86. Vainzof M., Passos-Bueno M.R., Moreira E.S., et al. The sarcoglycan complex in the six autosomal recessive limb-girdle (AR-LGMD) muscular dystrophies. Hum Mol Genet. 5:1996;1963-1969.
87. Vainzof M., Moreira E.S., Canovas M., et al. Partial α-sarcoglycan deficiency associated with the retention of the SG complex in a LGMD2D family. Muscle Nerve. 23:2000;984-988.
88. Bushby K.M.D., Beckmann J.S. Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC workshop on limb-girdle muscular dystrophies. Neuromuscul Disord. 5:1995;71-74.
89. Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 3:(4):2002;285-298.
90. Politano L.P., Nigro V., Aurino S., et al. Multiple heterozygosity for different muscle genes is not rare among individuals with pauci-symptomatic hyperckmia. Neuromuscul Disord. 12:(7-8):2002;733. [Seventh International Congress of the World Muscle Society].
91. Iannaccone S.T., Muirhead D., Elmonoufy N., et al. Partial Telethonin deficiency in severely affected north American LGMD patients. Neuromuscul Disord. 12:2002;732. [Seventh International Congress of the World Muscle Society].
92. Valle G., Faulkner G., De Antoni A., et al. Telethonin, a novel sarcomeric protein of heart and skeletal muscle. FEBS Lett. 415:1997;163-168.
93. Halliday W., Greenberg C.R., Wrogemann K., et al. Genetic heterogeneity of limb girdle muscular dystrophy in Manitoba Hutterites. Am J Hum Genet. 63:(Suppl):1998;A392. [Abstract 2280].
94. Shokeir M.H., Kobrinsky N.L. Autosomal recessive muscular dystrophy in Manitoba Hutterites. Clin Genet. 9:(2):1976;197-202.
95. Weiler T., Greenberg C.R., Nylen E., et al. Limb girdle muscular dystrophy in Manitoba Hutterites does not map to any of the known LGMD loci. Am J Med Genet. 72:(3):1997;363-368.
96. Weiler T., Greenberg C.R., Zelinski T., et al. A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another LGMD locus. Am J Hum Genet. 63:1998;140-147.
97. Fridell R.A., Harding L.S., Bogerd H.P., Cullen B.R. Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology. 209:(2):1995;347-357.
98. Slack F.J., Ruvkun G. A novel repeat domain that is often associated with RING finger and B-box motifs. Trends Biochem Sci. 23:(12):1998;474-475.
99. Driss A., Amouri R., Ben Hamida C., et al. A new locus for autosomal recessive limb-girdle muscular dystrophy in a large consanguineous Tunisian family maps to chromosome 19q13.3. Neuromuscul Disord. 10:(4-5):2000;240-246.
100. Brockington M., Blake D.J., Prandini P., et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet. 69:(6):2001;1198-1209.
101. Fukuyama Y., Kawazura M., Haruna H. A peculiar form of congenital progressive muscular dystrophy: report of fifteen cases. Paediatr Univ Tokyo. 4:1960;5-8.
102. Brockington M., Blake D.J., Brown S.C., Muntoni F. The gene for a novel glycosyltransferase is mutated in congenital muscular dystrophy MDC1C and limb girdle muscular dystrophy 2I. Neuromuscul Disord. 12:(3):2002;233-234.
103. Topaloglu H., Brockington M., Yuva Y., et al. FKRP gene mutations cause congenital muscular dystrophy, mental retardation and cerebellar cysts. Neurology. 60:2003;988-992.
104. Prandini P., Boito C., Bakay M., Angelini C., Hoffman E., Pegoraro E. Discordant clinical phenotype in a family affected with LGMD2I. J Neurol Sci. 199:(Suppl 1):2002.
105. Paula F., Starling A., Jazedje T., et al. Fukutin related protein gene mutations in Brazilian limb girdle muscular dystrophy families. Neuromuscul Disord. 12:(7-8):2002;. [Seventh World Muscular Society Congress].
106. Mercuri E., Brockington M., Straub V., et al. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol. 53:2003;537-542.
107. Haravuori H., Makela-Bengs P., Udd B., et al. Assignment of the tibial muscular dystrophy locus to chromosome 2q31. Am J Hum Genet. 62:(3):1998;620-626.
108. Labeit S., Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science. 270:(5234):1995;293-296.
109. Poppe M., Cree L., Bourke J., et al. The phenotype of limb-girdle muscular dystrophy type 2I. Neurology. 60:2003;1246-1251.